Polarized Trafficking of K+ Channels in the Kidney
肾脏 K 通道的极化运输
基本信息
- 批准号:7913908
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2010-09-29
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAddressApicalArtsAutomobile DrivingBinding SitesBiologicalCell membraneCell surfaceCellsCellular biologyClathrin AdaptorsComplexDataDietary PotassiumDiseaseDuct (organ) structureElectrophysiology (science)EndocytosisEquilibriumGoalsHealthHomeostasisImaging TechniquesInvestigationIon ChannelKCNJ1 geneKCNJ1 proteinKidneyKnockout MiceLocationMembraneMembrane Protein TrafficMembrane ProteinsMethodsMineralsMolecularMolecular GeneticsPTB DomainPathway interactionsPhysiologicalPhysiologyPotassiumPotassium ChannelPrincipal InvestigatorProcessProtein IsoformsPublishingRetrievalRouteSignal TransductionSodium ChlorideSorting - Cell MovementSurfaceTestingWorkapical membraneattenuationbasebasolateral membranedensitydesigninsightinterdisciplinary approachmembermembrane activitynovelprogramsprotein transportprototypescaffoldsecretion processsrc-Family Kinasestrafficking
项目摘要
DESCRIPTION (provided by applicant): Polarized expression of different potassium channel subtypes on opposite membrane domains of renal collecting duct cells insures an efficient and precisely controlled potassium secretion process, critical for potassium homeostasis. The overarching goal of the present proposal is to develop a mechanistic explanation of the poorly understood trafficking processes that drive polarized localization and physiologically regulate the cell surface density of two closely related channels in the collecting duct (the apical secretory channel, Kir1.1 (ROMK), and a basolateral membrane channel, Kir2.3). The program logically builds on our recent discoveries, defining the trafficking signals in these channels and the elucidating the intracellular sorting and retention machinery that interacts with them. Specifically, we will address the following critical and timely questions: 1. How are the polarized trafficking signals in basolateral membrane Kir channels interpreted? Here, we test a novel mechanism whereby independent signals in Kir2.3 sequentially interact with intracellular sorting machinery and a PDZ scaffold complex, Lin-7/CASK, to drive basolateral-directed traffic in the biosynthetic and endocytotic pathways. 2. Does Lin-7C interaction regulate basolateral Kir channel in the renal cortical collecting duct during potassium adaptation? Collecting duct specific Lin-7C knockout mice will be examined to test the hypothesis that the increase in basolateral membrane conductance in potassium adaptation is influenced by interaction with a specific Lin-7 isoform, Lin-7C. 3. What is the molecular mechanism by which Kir1.1 (ROMK) channel density is controlled by endocytosis. Here we test the hypothesis that a "NPXY"-type signal in Kir1.1 serves as recognition site for binding to a member of a new class of clathrin-adaptor proteins, ARH, and this interaction marks Kir1.1 channels for rapid endocytosis. Moreover, ARH knockout mice will be used to test the hypothesis that physiological attenuation of Kir1.1 channels at the apical membrane activity is influenced by interaction with ARH. In doing so, the program of investigation will provide new insights into the fundamental trafficking mechanisms that underpin potassium secretion in health and to understand what happens when trafficking signals and trafficking machinery goes wrong in disease.
Project Narrative: Potassium channels that underpin potassium balance must be precisely organized at two polarized membrane domains in the Kidney for efficient renal potassium secretion. Disruption of ion channel trafficking and surface expression can, in fact, have devastating consequences on salt and mineral balance. Despite its importance, a long-standing and fundamental question in cell biology and physiology has been how the number and location of these membrane proteins are precisely controlled. In the present proposal, we elucidate the molecular mechanisms driving membrane trafficking of these channels in health and study what may happen when these processes go awry in disease. Thus, the studies should provide novel insights into the molecular basis of renal K handling and K homeostasis in health and disease while illuminating fundamental mechanisms of membrane protein targeting in the kidney.
描述(由申请人提供):肾集合管细胞相对膜结构域上不同钾通道亚型的极化表达确保了有效且精确控制的钾分泌过程,这对钾稳态至关重要。本提案的总体目标是开发一种机制解释的知之甚少的贩运过程,驱动极化定位和生理调节细胞表面密度的两个密切相关的渠道在集合管(顶端分泌通道,Kir1.1(ROMK),和基底外侧膜通道,Kir2.3)。该计划在逻辑上建立在我们最近的发现,定义这些通道中的贩运信号,并阐明与它们相互作用的细胞内分选和保留机制。具体而言,我们将解决以下关键和及时的问题:1。基底外侧膜Kir通道中的极化运输信号如何解释?在这里,我们测试了一种新的机制,即Kir2.3中的独立信号依次与细胞内分选机制和PDZ支架复合物Lin-7/CASK相互作用,以驱动生物合成和内吞途径中的基底侧定向交通。2.在钾适应过程中,Lin-7 C相互作用是否调节肾皮质集合管基底外侧Kir通道?将检查集合管特异性Lin-7 C敲除小鼠以检验钾适应中基底外侧膜电导的增加受与特异性Lin-7同种型Lin-7 C的相互作用影响的假设。3. Kir1.1(ROMK)通道密度受内吞作用控制的分子机制是什么?在这里,我们测试的假设,“NPXY”型信号Kir1.1作为识别位点结合到一个新的网格蛋白接头蛋白,ARH类的成员,这种相互作用标志着Kir1.1通道快速内吞作用。此外,ARH基因敲除小鼠将被用于测试的假设,Kir1.1通道在顶端膜活动的生理衰减的影响与ARH的相互作用。在这样做的过程中,调查计划将提供新的见解,以支持钾分泌的基本贩运机制,并了解当贩运信号和贩运机制在疾病中出错时会发生什么。
项目叙述:钾通道是钾平衡的基础,必须在肾脏的两个极化膜区域精确地组织起来,以实现有效的肾脏钾分泌。事实上,离子通道运输和表面表达的破坏可能对盐和矿物质平衡产生破坏性后果。尽管其重要性,细胞生物学和生理学中一个长期存在的基本问题是如何精确控制这些膜蛋白的数量和位置。在本提案中,我们阐明了在健康状态下驱动这些通道的膜运输的分子机制,并研究了当这些过程在疾病中出错时可能发生的情况。因此,这些研究应该提供新的见解,在健康和疾病的肾K处理和K稳态的分子基础,同时阐明膜蛋白靶向肾脏的基本机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul A Welling其他文献
Paul A Welling的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul A Welling', 18)}}的其他基金
Multigene Kinase Network, Kidney Transport and Salt in Essential Hypertension
原发性高血压中的多基因激酶网络、肾脏转运和盐
- 批准号:
7938618 - 财政年份:2009
- 资助金额:
$ 10万 - 项目类别:
Multigene Kinase Network, Kidney Transport and Salt in Essential Hypertension
原发性高血压中的多基因激酶网络、肾脏转运和盐
- 批准号:
7820603 - 财政年份:2009
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 10万 - 项目类别:
Research Grant